Cart
sales@molnova.com
KDM2B-IN-2
CAS No. 1965248-01-4
KDM2B-IN-2( —— )
Catalog No. M35115 CAS No. 1965248-01-4
KDM2B-IN-2 is a potent histone demethylase (kdm2b) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 154 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 407 | In Stock |
|
| 50MG | 594 | In Stock |
|
| 100MG | 828 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1702 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKDM2B-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionKDM2B-IN-2 is a potent histone demethylase (kdm2b) inhibitor.
-
DescriptionKDM2B-IN-2, a potent histone demethylase (kdm2b) inhibitor with an IC50 of 0.021 μM in a KDM2B TR-FRET assay. KDM2B-IN-2 can be used for hyperproliferative diseases research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHistone Demethylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1965248-01-4
-
Formula Weight430.59
-
Molecular FormulaC21H26N4O2S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 31.25 mg/mL (72.57 mM; ultrasonic and heat to 80°C)
-
SMILESO=S(=O)(N1CCN=C1N1CCN(CC1)C1CCC1)c1ccc(cc1)-c1ccsc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Brian K. Albrecht, et al. 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors. Patent WO2016112251A1.
molnova catalog
related products
-
SD-70
A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program.
-
TAK-418
TAK-418 is a selective and orally active inhibitor of LSD1/KDM1A enzyme with an IC50 of 2.9 nM.
-
D-alpha-Hydroxygluta...
A competitive inhibitor of multiple α-KG-dependent dioxygenases, including histone demethylases and the TET family of 5-methlycytosine (5mC) hydroxylases.
